Skip page top navigationFDA Logo--links to FDA home page Logo of and Link to start page of Office of Regulatory Affairs, U.S. Food and Drug Administration U.S. Food and Drug Administration Office of Regulatory Affairs HHS Logo and link to Department of Health and Human Services website

FDA Home Page | Federal-State | Import Program | Compliance | Inspection | Science | ORA Search

Updated: 2005-11-29

Sec. 590.300 Direct Reference Authority for Pseudomonas Contamination of Cosmetics Used In The Eye Area (CPG 7128.03)

REGULATORY ACTION GUIDANCE:

The following represents criteria for deciding when direct reference seizure to *the Office of General Counsel* through Division of Compliance Management and Operations (HFC-210) is appropriate:

Any cosmetic product intended for use in the eye area which contains Pseudomonas aeruginosa.

REMARKS:

Direct reference seizure recommendations should be accompanied by complete labeling and worksheets. Positive identification using the method found in Chapter 25 of the Bacteriological Analytical Manual (BAM) is necessary to support the charge. Speciate Pseudomonas isolates using biochemical tests (BAM, Chapter 25) or appropriate commercial identification kits.

SPECIMEN CHARGE:
The article (was adulterated when introduced into and while in interstate commerce) (is adulterated while held for sale after shipment in interstate commerce) within the meaning of the Act, 21 U.S.C. 361(a), in that it contains a poisonous or deleterious substance, Pseudomonas aeruginosa, which may render it injurious to users under such conditions of use as are customary or usual.

*Material between asterisks is new or revised.*

Issued: 4/10/91

Revised: 8/96, 5/2005